Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL495591 | 0.97 | LMNA (0.38) | LMNACHRM2 | |
| SCHEMBL329938 | 0.93 | ALDH1A1 (0.36) | LMNACHRM2 | |
| SCHEMBL23526536 | 0.93 | LMNA (0.33) | LMNACHRM2 | |
| SCHEMBL19923790 | 0.93 | LMNA (0.33) | LMNACHRM2 | |
| SCHEMBL16862734 | 0.90 | CHRM2 (0.39) | LMNACHRM2 | |
| SCHEMBL17750082 | 0.89 | LMNA (0.46) | LMNA | |
| SCHEMBL758748 | 0.89 | LMNA (0.41) | LMNACHRM2 | |
| SCHEMBL9579884 | 0.89 | CA12 (0.48) | LMNACHRM2 | |
| SCHEMBL25917071 | 0.89 | LMNA (0.33) | LMNACHRM2 | |
| SCHEMBL1070733 | 0.87 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10941341-B2 | Etching composition additive, method for preparing the same and etching composition comprising the same | SK INNOVATION CO., LTD. (KR) | 2021-03-09 | — | — | US | disclosed |
| US-10781371-B2 | Etchant composition and silane compound | SK INNOVATION CO., LTD. (KR) | 2020-09-22 | — | — | US | disclosed |
| US-20200131438-A1 | ETCHING COMPOSITION ADDITIVE, METHOD FOR PREPARING THE SAME AND ETCHING COMPOSITION COMPRISING THE SAME | SK INNOVATION CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10781371-B2 | Etchant composition and silane compound | H1-0, H1-5, ALOX5 | LMNA 1916/4885CHRM2 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.